Ekso Bionics (EKSO) Reports Q4 Loss of $0.15/Share
Tweet
Share
E-mailGet Alerts EKSO Hot Sheet
Join SI Premium – FREE
Ekso Bionics (NASDAQ: EKSO) reported Q4 EPS of ($0.15), versus ($0.34) reported last year. Revenue for the quarter came in at $2.5 million, versus $2.6 million reported last year.
For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- JPMorgan Downgrades HCL Technologies (HCLT:IN) to Underweight
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
